Araim Pharmaceuticals

    OverviewSuggest Edit

    Araim Pharmaceuticals is a company focused on the discovery of a global master regulator, the Innate Repair Receptors (IRR), that produces cellular and tissue repair in various disease states. Its lead compound Cibinetide, is focused on addressing unmet needs in neuroscience and diabetes complications.
    TypePrivate
    Founded2006
    Websitearaimpharma.com

    Latest Updates

    Employees (est.) (Sept 2020)6
    Cybersecurity ratingBMore

    Key People/Management at Araim Pharmaceuticals

    Anthony Cerami

    Anthony Cerami

    Founder
    Ferdinand Breedveld

    Ferdinand Breedveld

    Chief Executive Officer and Chairman of the Board
    Michael Brines

    Michael Brines

    Co-Founder and Chief Science Officer
    Ann Dunne

    Ann Dunne

    President
    Rita Kirk

    Rita Kirk

    Vice President of Operations
    Show more

    Araim Pharmaceuticals Financials and Metrics

    Summary Metrics

    Founding Date

    2006

    Araim Pharmaceuticals Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    86/100

    SecurityScorecard logo

    Araim Pharmaceuticals Online and Social Media Presence

    Embed Graph

    Araim Pharmaceuticals Frequently Asked Questions

    • When was Araim Pharmaceuticals founded?

      Araim Pharmaceuticals was founded in 2006.

    • Who are Araim Pharmaceuticals key executives?

      Araim Pharmaceuticals's key executives are Anthony Cerami, Ferdinand Breedveld and Michael Brines.

    • How many employees does Araim Pharmaceuticals have?

      Araim Pharmaceuticals has 6 employees.

    • Who are Araim Pharmaceuticals competitors?

      Competitors of Araim Pharmaceuticals include Diasome, Follicum and Metabolic Solutions Development.